<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Einstein (Sao Paulo)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Einstein (Sao Paulo)</journal-id>
      <journal-title-group>
        <journal-title>Einstein</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1679-4508</issn>
      <issn pub-type="epub">2317-6385</issn>
      <publisher>
        <publisher-name>Instituto Israelita de Ensino e Pesquisa Albert Einstein</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25167339</article-id>
      <article-id pub-id-type="pmc">4872948</article-id>
      <article-id pub-id-type="publisher-id">S1679-45082014RC2579</article-id>
      <article-id pub-id-type="doi">10.1590/S1679-45082014RC2579</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Rhino facial zygomycosis: case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Souza</surname>
            <given-names>Juliana Miguita e</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sproesser</surname>
            <given-names>Antonio Jos&#xE9;</given-names>
            <suffix>Junior</suffix>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Felippu</surname>
            <given-names>Alexandre</given-names>
            <suffix>Neto</suffix>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fuks</surname>
            <given-names>Florencia Barbero</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Oliveira</surname>
            <given-names>Carlos Augusto Cardim</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Hospital Israelita Albert Einstein, S&#xE3;o Paulo, SP, Brazil.</aff>
      <author-notes>
        <corresp> Autor correspondente: Juliana Miguita e Souza &#x2212; Hospital Israelita Albert Einstein, Avenida Albert Einstein, 627/701 &#x2212; Jardim Leonor &#x2212; CEP: 05652-900 &#x2212; S&#xE3;o Paulo, SP, Brasil &#x2212; Tel.: (11) 2151-1233 E-mail: <email>msjuliana@uol.com.br</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Jul-Sep</season>
        <year>2014</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Jul-Sep</season>
        <year>2014</year>
      </pub-date>
      <volume>12</volume>
      <issue>3</issue>
      <fpage>347</fpage>
      <lpage>350</lpage>
      <history>
        <date date-type="received">
          <day>26</day>
          <month>2</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>12</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This work is licensed under a Creative Commons Attribution 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Zygomycosis is an invasive disease that affects both immunocompetent and immunocompromised, depending on the type of strain. This disease diagnosis is clinical and histopathological, and its treatment is based on antifungal therapy and surgical cleaning. This paper reports a case of a boy with invasive zygomycosis rinofacial who final treatment was successful after underwent antifungal and surgical therapies.</p>
      </abstract>
      <kwd-group>
        <kwd>Zygomycosis/therapy</kwd>
        <kwd>Zygomycosi/diagnosis</kwd>
        <kwd>Magnetic resonance imaging</kwd>
        <kwd>Tomography</kwd>
        <kwd>X-ray computed</kwd>
        <kwd>Case reports</kwd>
      </kwd-group>
      <counts>
        <fig-count count="10"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="10"/>
        <page-count count="4"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Zygomycosis is a rare fungal, severe, invasive and lethal disease with rapid progress. This disease is prominent in countries with warm and humid climate.<sup>(<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>)</sup> Its incidence in Brazil is unknown because of the scarcity of reports in the literature, but it is well known that several cases occur in north and northeast region of the country.<sup>(<xref rid="B3" ref-type="bibr">3</xref>)</sup> There is a tendency in international literature, mainly in immunocompromised patients, of increase in the incidence of fungal invasive disease. An incidence of zygomycosis of 2-4% was found in autopsies of cancer patients both in Japan and the United States.<sup>(<xref rid="B3" ref-type="bibr">3</xref>)</sup>
</p>
      <p>The zygomycosis has several clinical presentations (cutaneous, pulmonary, systemic and gastrointestinal), however, the rhino-orbital-cerebral is the most common one.<sup>(<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>)</sup>
</p>
      <p>Zygomycosis etiologic agents originate from <italic>Mucorales</italic> that primarily affects immunocompromised patients and base disease carriers, and from the <italic>Entomophthorales</italic> that is commonly found in immunocompetent individuals and rarely causes angioinvasive disease.<sup>(<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B5" ref-type="bibr">5</xref>)</sup>
</p>
      <p>The diagnosis is based on a combination of mycologic and histopathological tests, and clinical presentation.<sup>(<xref rid="B6" ref-type="bibr">6</xref>)</sup> The fungal infection could be determined by direct examination with potassium hydroxide (KOH) and culture on Sabouraud&#x2019;s medium. The histopathological analysis shows nonseptate hyphae with branches at 90&#xB0; angle, which usually does not invade tissues and blood vessels.<sup>(<xref rid="B7" ref-type="bibr">7</xref>)</sup>
</p>
      <p>Common symptoms include nasal congestion, nasal discharge and chronic sinusitis,<sup>(<xref rid="B8" ref-type="bibr">8</xref>)</sup> however, the infection may also present fever, lethargy, headache, retro-orbital pain, sudden vision loss, proptosis, periorbital cellulitis, epistasis and seizure.<sup>(<xref rid="B9" ref-type="bibr">9</xref>)</sup>
</p>
      <p>At physical examination necrotic crusts can appear on the nasal septum, turbinates and palate. Initially, the orbital involvement can be show by proptosis and periorbital cellulitis with subsequent ophtalmoplegy and amaurosis.<sup>(<xref rid="B6" ref-type="bibr">6</xref>)</sup> Later, the spread of the infection to the central nervous system can occur by the ethmoid bone and sphenoid sinus after bone destruction.</p>
      <p>Treatment success depends on rapid diagnosis<sup>(<xref rid="B5" ref-type="bibr">5</xref>)</sup> and the combined approach of surgical procedures and antifungal therapy.<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup> The amphotericin B is the drug of choice for initial treatment. There are studies reporting increase of up to 79% in patient survival after adoption of this drug. For the effective control of the disease, high doses of amphotericin B must be used. These doses range from 0.8 to 1.5mg/kg daily, which correspond to doses very close to nephrotoxic levels.<sup>(<xref rid="B9" ref-type="bibr">9</xref>)</sup>
</p>
      <p>The use of hematopoietic as stimulating factors and hyperbaric oxygen therapy may be beneficial, but few studies had established the efficacy of these procedures.<sup>(<xref rid="B10" ref-type="bibr">10</xref>)</sup> There are also studies reporting success by the oral administration of potassium iodide.<sup>(<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B6" ref-type="bibr">6</xref>)</sup> Surgical debridement, which main goal is to remove as much devitalized tissue as possible, in addition to establish adequate sinus drainage, has a significant impact on the disease morbidity and mortality.<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup>
</p>
      <p>Prevention of the disease consists in environmental control, avoidance or reduction of direct contact with fungal propagules, which are found in plants, flowers and house dust.<sup>(<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B10" ref-type="bibr">10</xref>)</sup>
</p>
      <p>Poor prognosis factors are delayed initiation of treatment, intracranial (hemiplegia and hemiparesis), palate or orbital involvement as well as bilateral facial sinus involvement, and facial necrosis.<sup>(<xref rid="B7" ref-type="bibr">7</xref>)</sup>
</p>
      <p>This paper reports a case of immunocompetent patient with late diagnosis and who initially had unfavorable clinical evolution. Treatments were based on the experience of the responsible physician and case reports previously published in the literature. The result was total remission of the disease and no sequelae.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 9-year-old boy from city of Bel&#xE9;m (PA) was referred to the pediatric unit of the <italic>Hospital Israelita Albert Einstein</italic> (HIAE) in S&#xE3;o Paulo, for treatment of rhino facial zygomycosis. He was a previously healthy and had a habit of smelling roses. In March 2010, the patient presented tumors inside his left nostril that increased progressively. The child was diagnosed with cellulitis and treated with antibiotics, topic and systemic corticoids, however, the lesions did not improve but got worse. The computed tomography of the skull revealed sinusopathy of left paranasal sinuses (<xref ref-type="fig" rid="f01">Figure 1</xref>). Almost 3 months later, the patient was submitted to surgical cleaning of facial sinus along with resection of lesion on nasal wall. The histopathological exam showed zygomycosis. After two weeks, he become to present painful cellulitis in orbital region (<xref ref-type="fig" rid="f02">Figure 2</xref>). Treatment was initiated with amphotericin B and caspofungin. Despite the introduction of medication, the disease continued to progress and the pain worsened, being also observed a decrease in ocular motility and proptosis. The magnetic resonance test showed periorbital invasion with probable contiguity to the skull base (<xref ref-type="fig" rid="f03">Figure 3</xref>). With this clinical picture, the child was submitted again to two surgical cleanings, and the antifungal treatment was extended. Subsequently, the patient condition improved and lesions and periorbital edema reduced. The <italic>Conidiobollus sp</italic> was isolated from paranasal secrections culture.</p>
      <p>
<fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Computed tomography of the face sinuses. Signs of persistence of lesion in edges of surgical sites toward left pterygopalatine fossa, remaining antral cavities to the left and large orbital component also to the left, which infiltrated pre and post-septal plans and the lachrymal apparatus</title></caption><graphic xlink:href="1679-4508-eins-12-3-0347-gf01"/></fig>
</p>
      <p>
<fig id="f02" orientation="portrait" position="float"><label>Figure 2</label><caption><title>External involvement of facial mycosis</title></caption><graphic xlink:href="1679-4508-eins-12-3-0347-gf02"/></fig>
</p>
      <p>
<fig id="f03" orientation="portrait" position="float"><caption><title>Figure 3 (A and B). Infiltrative lesion that affects the face and sinuses, especially the left orbital region, nose and oropharynx, with greater accumulation of secretions in the sinuses and slight increase in edema and/or inflammation at the base of the anterior cerebral fosse</title></caption><graphic xlink:href="1679-4508-eins-12-3-0347-gf03"/></fig>
</p>
      <p>After stabilization of patient&#x2019;s condition, he returned to Bel&#xE9;m to complete the treatment with amphotericin B. The appearance of side effects such as hypocalcemia, hyperthermia and body pain caused his hospitalization at intensive care unit for hemodynamic and hydroelectrolytic stability. After his discharge from intensive care unit, the treatment was replaced by oral antifungal posaconazole that caused a worsening in clinical picture.</p>
      <p>The patient returned to our service in August 2010 and a new magnetic resonance exam of the skull showed progression of infiltrative lesions affecting the left hemiface, orbits and large extension of ethmoid and sphenoid sinus, besides affect the pachymeningeal (<xref ref-type="fig" rid="f04">Figure 4</xref>). Because of clinical picture worsening, persistence fever and complications related to hospitalization a therapeutic scheme was used with amphotericin B, caspofungin, terbinafine, terbinafine, itraconazole, corticoids, acyclovir, erythropoietin, ceftriaxone, cefepime and ciprofloxacin at different times and also hyperbaric oxygenotherapy. Fifteen days after the last session of hyperbaric chamber, a magnetic resonance showed lesions but without signs of invasion of healthy tissues (<xref ref-type="fig" rid="f05">Figure 5</xref>). After almost 2 months, the patients underwent another surgical cleaning and at that time there were improvement on obstructive symptoms and practically, the cure of the disease.</p>
      <p>
<fig id="f04" orientation="portrait" position="float"><label>Figure 4</label><caption><title>Thickening and enhancement involving bulb and olfactory nerves and the floor of the anterior cranial fossa. There is displacement of the base of the left frontal lobe and suggestive lesions of inflammation and/or edema in straight orbital`s frontal gyri at the same side</title></caption><graphic xlink:href="1679-4508-eins-12-3-0347-gf04"/></fig>
</p>
      <p>
<fig id="f05" orientation="portrait" position="float"><label>Figure 5</label><caption><title>Decreased infiltrative lesion that affects the subcutaneous tissue, mainly in the left periorbital region and reduction of proptosis at the same side. Lesion reduction in nasopharynx, hypopharynx and sinuses, compared to previous images</title></caption><graphic xlink:href="1679-4508-eins-12-3-0347-gf05"/></fig>
</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The <italic>Conid</italic>
<italic>iobollus sp</italic> is a saprophytic organism that grows on the floor and propagules in vegetation. This parasite often affect arthropods; human infection is accidental.<sup>(<xref rid="B10" ref-type="bibr">10</xref>)</sup> Fungal infections can be acquired by inhalation or direct inoculation, being this latter the case of our patient.<sup>(<xref rid="B8" ref-type="bibr">8</xref>)</sup>
</p>
      <p>The most common presentation of the disease is an initial clinical picture with nasal lesion of rapid growing that provoke obstructive signs that, within few weeks, spread to periorbital region and cause edema, ptosis and proptosis.<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup>
</p>
      <p>The late diagnosis, about 3 months, justifies the high morbidity of this disease and it can be explained by several types of differential diagnosis for the initial symptoms.<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup> In our case, the skin lesion was first treated as impetigo and other obstructive symptoms such as sinusitis. The lack of therapeutic response resulted in surgical cleaning and biopsy.<sup>(<xref rid="B3" ref-type="bibr">3</xref>)</sup>
</p>
      <p>It is important to mention that intravenous amphotericin B has been considered the treatment of choice.<sup>(<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>)</sup> In our patient, this fact was well registered because in the period that he received this medication by the adequate route the response was more satisfactory. However for a completely adequate treatment it is necessary to be careful with drug administration in order to avoid side effects, which were also observed in the child in our report.</p>
      <p>The hyperbaric oxygenotherapy might contributed to the improvement, although there is no evidences of its use for treatment of zygomycosis.<sup>(<xref rid="B10" ref-type="bibr">10</xref>)</sup> The surgical cleaning is an essential part of the therapeutic strategy, because it removes as much infected material as possible and enables to observe the sinus drainage, which was observed in our case. For this reason, the use of surgical cleaning should be emphasized.<sup>(<xref rid="B7" ref-type="bibr">7</xref>)</sup>
</p>
    </sec>
    <sec sec-type="conclusions">
      <title>CONCLUSION</title>
      <p>The zygomycosis is a severe fungal disease that can affect both immunocompetent and immunocompromised individuals.</p>
      <p>The literature shows that rapid diagnosis and early adequate treatment are fundamental for the disease prognosis. The patient described in this case, although with little delay in the diagnosis, had a favorable progress due to treatments used.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFER&#xCA;NCIAS</title>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prabhu</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment</article-title>
          <source>Clin Microbiol Infect</source>
          <year>2004</year>
          <volume>10</volume>
          <issue>Suppl 1</issue>
          <fpage>31</fpage>
          <lpage>47</lpage>
          <comment>Review</comment>
          <pub-id pub-id-type="pmid">14748801</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoogendijk</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>van Heerden</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Pretorius</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Vismer</surname>
              <given-names>HF</given-names>
            </name>
            <name>
              <surname>Jacobs</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>Rhino-orbitocerebral entomophthoramycosis</article-title>
          <source>Int J Oral Maxillofac Surg</source>
          <year>2006</year>
          <volume>35</volume>
          <issue>3</issue>
          <fpage>277</fpage>
          <lpage>280</lpage>
          <pub-id pub-id-type="pmid">16280238</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tadano</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Paim</surname>
              <given-names>NP</given-names>
            </name>
            <name>
              <surname>Hueb</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fontes</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
          <article-title>Entomophthoramycosis (zygomycosis) caused by Conidiobolus coronatus in Mato Grosso (Brazil): case report</article-title>
          <source>Rev Soc Bras Med Trop</source>
          <year>2005</year>
          <volume>38</volume>
          <issue>2</issue>
          <fpage>188</fpage>
          <lpage>190</lpage>
          <comment>Portuguese</comment>
          <pub-id pub-id-type="pmid">15821798</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mohanty</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dhar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dwivedi</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Mucormycosis</article-title>
          <source>Tropl Doct</source>
          <year>2010</year>
          <volume>40</volume>
          <issue>2</issue>
          <fpage>127</fpage>
          <lpage>128</lpage>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marques</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Camargo</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Abbade</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Marques</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Mucormicose: infec&#xE7;&#xE3;o oportun&#xED;stica grave em paciente imunossuprimido. Relato de caso</article-title>
          <source>Diagn Tratamento</source>
          <year>2010</year>
          <volume>15</volume>
          <issue>2</issue>
          <fpage>64</fpage>
          <lpage>68</lpage>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Severo</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Guazzelli</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Severo</surname>
              <given-names>LC</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Zigomicose Curso de Atualiza&#xE7;&#xE3;o-micoses</article-title>
          <source>J Bras Pneumol</source>
          <year>2010</year>
          <volume>36</volume>
          <issue>1</issue>
          <fpage>134</fpage>
          <lpage>141</lpage>
          <comment>Review</comment>
          <pub-id pub-id-type="pmid">20209316</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dannaoui</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Meletiadis</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mouton</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Meis</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Verweij</surname>
              <given-names>PE</given-names>
            </name>
            <collab>Eurofung Network</collab>
          </person-group>
          <article-title>In vitro susceptibilities of zygomycetes to conventional and new antifungals</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2003</year>
          <volume>51</volume>
          <issue>1</issue>
          <fpage>45</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">12493786</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Michael</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Michael</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Mathews</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Rupa</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Unusual presentation of entomophthoromycosis</article-title>
          <source>Indian J Med Microbiol</source>
          <year>2009</year>
          <volume>27</volume>
          <issue>2</issue>
          <fpage>156</fpage>
          <lpage>158</lpage>
          <pub-id pub-id-type="pmid">19384042</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xavier</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Korn</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Granato</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Mucormicose rinocerebral: apresenta&#xE7;&#xE3;o de caso com sobrevida e revis&#xE3;o de literatura</article-title>
          <source>Rev Bras Otorrinolaringol</source>
          <year>2004</year>
          <volume>70</volume>
          <issue>5</issue>
          <fpage>710</fpage>
          <lpage>714</lpage>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lithander</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Louon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Worthing</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ganesh</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Al-Lawatia</surname>
              <given-names>YM</given-names>
            </name>
            <name>
              <surname>Elamin</surname>
              <given-names>A</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Orbital entomophthoramycosis in an infant: recovery following surgical debridement, combination antifungal therapy and use of hiperbaric oxigen</article-title>
          <source>Br J Ophthalmol</source>
          <year>2001</year>
          <volume>85</volume>
          <issue>3</issue>
          <fpage>374</fpage>
          <lpage>375</lpage>
          <pub-id pub-id-type="pmid">11277105</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article id="TRen" article-type="translation" xml:lang="pt">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Relato De Caso</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Zigomicose rino facial: relato de caso</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Souza</surname>
            <given-names>Juliana Miguita e</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sproesser</surname>
            <given-names>Antonio Jos&#xE9;</given-names>
            <suffix>Junior</suffix>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Felippu</surname>
            <given-names>Alexandre</given-names>
            <suffix>Neto</suffix>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fuks</surname>
            <given-names>Florencia Barbero</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Oliveira</surname>
            <given-names>Carlos Augusto Cardim de</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>1</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff2"><label>1</label>Hospital Israelita Albert Einstein, S&#xE3;o Paulo, SP, Brasil.</aff>
      <author-notes>
        <corresp> Autor correspondente: Juliana Miguita e Souza &#x2212; Hospital Israelita Albert Einstein, Avenida Albert Einstein, 627/701 &#x2212; Jardim Leonor &#x2212; CEP: 05652-900 &#x2212; S&#xE3;o Paulo, SP, Brasil &#x2212; Tel.: (11) 2151-1233 E-mail: <email>msjuliana@uol.com.br</email></corresp>
      </author-notes>
      <abstract>
        <p>A zigomicose &#xE9; uma doen&#xE7;a invasiva, que acomete tanto imunocompetentes como imunocomprometidos, dependendo do tipo da cepa. O diagn&#xF3;stico &#xE9; cl&#xED;nico e histopatol&#xF3;gico, e o tratamento &#xE9; baseado em antif&#xFA;ngico e em limpeza cir&#xFA;rgica. O presente relato de caso &#xE9; sobre um menino com zigomicose rinofacial invasiva com tratamento final bem-sucedido, ap&#xF3;s terapias antif&#xFA;ngicas e limpezas cir&#xFA;rgicas.</p>
      </abstract>
      <kwd-group>
        <kwd>Zigomicose/terapia</kwd>
        <kwd>Zigomicose/diagn&#xF3;stico</kwd>
        <kwd>Imagem por resson&#xE2;ncia magn&#xE9;tica</kwd>
        <kwd>Tomografia computadorizada por raios-x</kwd>
        <kwd>Relatos de casos</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <sec>
        <title>INTRODU&#xC7;&#xC3;O</title>
        <p>Zigomicose &#xE9; uma doen&#xE7;a f&#xFA;ngica rara, grave e invasiva, de evolu&#xE7;&#xE3;o r&#xE1;pida e fulminante, que predomina em pa&#xED;ses de clima &#xFA;mido e quente.<sup>(<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>)</sup> A incid&#xEA;ncia dessa doen&#xE7;a no Brasil &#xE9; desconhecida, j&#xE1; que existem apenas poucos relatos de casos descritos na literatura, por&#xE9;m sabe-se que h&#xE1; um predom&#xED;nio de casos nas Regi&#xF5;es Norte e Nordeste.<sup>(<xref rid="B3" ref-type="bibr">3</xref>)</sup> Na literatura mundial, existe uma tend&#xEA;ncia de aumento na incid&#xEA;ncia de doen&#xE7;as f&#xFA;ngicas invasivas, principalmente em pacientes imunodeprimidos. Tanto no Jap&#xE3;o como nos Estados Unidos, foi encontrada uma incid&#xEA;ncia de zigomicose de 2 a 4% nas aut&#xF3;psias de pacientes de centros oncol&#xF3;gicos.<sup>(<xref rid="B3" ref-type="bibr">3</xref>)</sup>
</p>
        <p>A zigomicose possui diversas apresenta&#xE7;&#xF5;es cl&#xED;nicas (cut&#xE2;nea, pulmonar, sist&#xEA;mica e gastrintestinal), por&#xE9;m a rino-orbito-cerebral &#xE9; a mais frequente.<sup>(<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>)</sup>
</p>
        <p>Os agentes etiol&#xF3;gicos s&#xE3;o zigomicetos de duas ordens: <italic>Mucorales</italic>, que acomete principalmente pacientes imunodeficientes e portadores de doen&#xE7;as de base, e <italic>Entomophthorales</italic>, que atinge pessoas imunocompetentes e raramente causa doen&#xE7;a angioinvasiva.<sup>(<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B5" ref-type="bibr">5</xref>)</sup>
</p>
        <p>O diagn&#xF3;stico est&#xE1; apoiado na correla&#xE7;&#xE3;o entre os exames micol&#xF3;gico e histopatol&#xF3;gico, e nas manifesta&#xE7;&#xF5;es cl&#xED;nicas.<sup>(<xref rid="B6" ref-type="bibr">6</xref>)</sup> A pesquisa do fungo pode ser realizada pelo exame direto com KOH e pela cultura em meio Sabouraud. A an&#xE1;lise histopatol&#xF3;gica revela a presen&#xE7;a de hifas n&#xE3;o septadas com ramifica&#xE7;&#xF5;es em 90&#xB0;, geralmente sem invas&#xE3;o de tecidos e de vasos sangu&#xED;neos.<sup>(<xref rid="B7" ref-type="bibr">7</xref>)</sup>
</p>
        <p>Os sintomas mais comuns incluem: obstru&#xE7;&#xE3;o nasal, coriza e sinusite cr&#xF4;nica,<sup>(<xref rid="B8" ref-type="bibr">8</xref>)</sup> por&#xE9;m a doen&#xE7;a pode se manifestar tamb&#xE9;m com febre, letargia, dor de cabe&#xE7;a, dor retro-orbit&#xE1;ria, perda abrupta de vis&#xE3;o, proptose, celulite periorbit&#xE1;ria, epistaxe e convuls&#xE3;o.<sup>(<xref rid="B9" ref-type="bibr">9</xref>)</sup>
</p>
        <p>Ao exame f&#xED;sico, podem ser encontradas crostas necr&#xF3;ticas no septo nasal, cornetos e p&#xE1;lato. O envolvimento orbit&#xE1;rio pode ser demonstrado, inicialmente, por proptose e celulite periorbit&#xE1;ria, com subsequente oftalmoplegia e amaurose.<sup>(<xref rid="B6" ref-type="bibr">6</xref>)</sup> Tardiamente a infec&#xE7;&#xE3;o pode se disseminar para o sistema nervoso central, por meio do etmoide e do seio esfenoidal, ap&#xF3;s destrui&#xE7;&#xE3;o &#xF3;ssea.</p>
        <p>O sucesso do tratamento depende da rapidez do diagn&#xF3;stico<sup>(<xref rid="B5" ref-type="bibr">5</xref>)</sup> e de uma abordagem combinada entre procedimento cir&#xFA;rgico e terapia antif&#xFA;ngica.<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup> A droga de escolha &#xE9; a anfotericina B. Existem trabalhos que mostram um aumento na sobrevida dos pacientes ap&#xF3;s a introdu&#xE7;&#xE3;o desse tratamento em at&#xE9; 79%. Para controle efetivo da doen&#xE7;a, devem-se usar doses elevadas, que variam de 0,8 a 1,5mg/kg/dia &#x2212; doses muito pr&#xF3;ximas dos n&#xED;veis nefrot&#xF3;xicos.<sup>(<xref rid="B9" ref-type="bibr">9</xref>)</sup>
</p>
        <p>A utiliza&#xE7;&#xE3;o de fatores de estimula&#xE7;&#xE3;o hematopoi&#xE9;tica e oxigenioterapia hiperb&#xE1;rica pode ser ben&#xE9;fica, por&#xE9;m poucos estudos comprovam a efic&#xE1;cia desses procedimentos.<sup>(<xref rid="B10" ref-type="bibr">10</xref>)</sup> H&#xE1; relatos descrevendo sucesso com a inclus&#xE3;o de iodeto de pot&#xE1;ssio via oral.<sup>(<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B6" ref-type="bibr">6</xref>)</sup> O debridamento cir&#xFA;rgico, o qual tem o objetivo de remover o m&#xE1;ximo de tecido desvitalizado poss&#xED;vel, al&#xE9;m de estabelecer adequada drenagem sinusal, tem grande impacto na morbimortalidade da doen&#xE7;a.<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup>
</p>
        <p>A preven&#xE7;&#xE3;o consiste no controle ambiental, evitando ou minimizando o contato direto com prop&#xE1;gulos f&#xFA;ngicos presentes em plantas, flores e na poeira dom&#xE9;stica.<sup>(<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B10" ref-type="bibr">10</xref>)</sup>
</p>
        <p>S&#xE3;o fatores de mau progn&#xF3;stico: atraso no in&#xED;cio do tratamento, envolvimento intracraniano (hemiplegia e hemiparesia), palatal ou orbital, assim como envolvimento bilateral de seios da face e a necrose facial.<sup>(<xref rid="B7" ref-type="bibr">7</xref>)</sup>
</p>
        <p>Este trabalho relatou o caso de um paciente imunocompentente, cujo diagn&#xF3;stico foi tardio e a evolu&#xE7;&#xE3;o cl&#xED;nica, inicialmente desfavor&#xE1;vel, sendo a maioria dos tratamentos baseada na experi&#xEA;ncia do m&#xE9;dico que o assistia e em relatos de casos encontrados na literatura, resultando em remiss&#xE3;o total do quadro, sem nenhuma sequela.</p>
      </sec>
      <sec>
        <title>RELATO DE CASO</title>
        <p>Paciente de 9 anos, g&#xEA;nero masculino, procedente de Bel&#xE9;m (PA), internado na enfermaria de pediatria do Hospital Israelita Albert Einstein (HIAE), em S&#xE3;o Paulo (SP), para tratamento de zigomicose rinofacial. Crian&#xE7;a previamente h&#xED;gida, com o h&#xE1;bito de cheirar rosas. Em mar&#xE7;o de 2010, apresentou tumora&#xE7;&#xE3;o em regi&#xE3;o interna da narina esquerda de aumento progressivo. Diagnosticada como celulite, o paciente foi tratado com antibi&#xF3;ticos e corticoides t&#xF3;picos e sist&#xEA;micos, sem melhora e at&#xE9; com piora da les&#xE3;o. Realizada tomografia computadorizada de cr&#xE2;nio que evidenciou sinusopatia de seios paranasais esquerdos (<xref ref-type="fig" rid="f06">Figura 1</xref>). Cerca de 3 meses depois, foi submetido &#xE0; limpeza cir&#xFA;rgica dos seios faciais com ressec&#xE7;&#xE3;o da les&#xE3;o de parede nasal. O exame histopatol&#xF3;gico evidenciou zigomicose. Duas semanas ap&#xF3;s, o paciente passou a apresentar celulite acompanhada de dor na regi&#xE3;o orbit&#xE1;ria (<xref ref-type="fig" rid="f07">Figura 2</xref>). Foram iniciadas anfotericina B e caspofungina. A doen&#xE7;a continuou a evoluir, apesar das medica&#xE7;&#xF5;es, com piora da dor, diminui&#xE7;&#xE3;o da mobilidade ocular e proptose. O exame de resson&#xE2;ncia magn&#xE9;tica mostrou invas&#xE3;o periorbit&#xE1;ria, com prov&#xE1;vel contiguidade para a base do cr&#xE2;nio (<xref ref-type="fig" rid="f08">Figura 3</xref>). <email>Co</email>m esse quadro, a crian&#xE7;a foi novamente submetida a duas limpezas cir&#xFA;rgicas, e o tratamento antif&#xFA;ngico foi prolongado. A partir de ent&#xE3;o, a evolu&#xE7;&#xE3;o passou a ser favor&#xE1;vel, com redu&#xE7;&#xE3;o das les&#xF5;es e do edema periorbit&#xE1;rio. Na cultura das secre&#xE7;&#xF5;es paranasais, foi isolado o fungo <italic>Conidiobollus sp</italic>.</p>
        <p>
<fig id="f06" orientation="portrait" position="float"><label>Figura 1</label><caption><title>Tomografia computadorizada de seios da face. Sinais de persist&#xEA;ncia de les&#xE3;o junto aos limites dos s&#xED;tios cir&#xFA;rgicos, na fossa pterigopalatina esquerda, nas cavidades antrais remanescentes &#xE0; esquerda e de maior componente orbit&#xE1;rio tamb&#xE9;m &#xE0; esquerda, infiltrando planos pr&#xE9; e p&#xF3;s-septais e o aparelho lacrimal</title></caption><graphic xlink:href="1679-4508-eins-12-3-0347-gf01-pt"/></fig>
</p>
        <p>
<fig id="f07" orientation="portrait" position="float"><label>Figura 2</label><caption><title>Acometimento externo da micose facial</title></caption><graphic xlink:href="1679-4508-eins-12-3-0347-gf02-pt"/></fig>
</p>
        <p>
<fig id="f08" orientation="portrait" position="float"><caption><title>Figura 3 (A e B). Les&#xE3;o infiltrativa que acomete a face e cavidades paranasais, principalmente na regi&#xE3;o orbit&#xE1;ria esquerda, nariz e orofaringe, com maior ac&#xFA;mulo de secre&#xE7;&#xE3;o nas cavidades paranasais e aumento discreto do edema e/ou processo inflamat&#xF3;rio na base da fossa cerebral anterior</title></caption><graphic xlink:href="1679-4508-eins-12-3-0347-gf03-pt"/></fig>
</p>
        <p>Ap&#xF3;s estabiliza&#xE7;&#xE3;o do quadro, a crian&#xE7;a retornou a Bel&#xE9;m para completar o tratamento com anfotericina B. O aparecimento de efeitos adversos da medica&#xE7;&#xE3;o, como hipocalcemia, hipertermia e dores no corpo, resultou em interna&#xE7;&#xE3;o em unidade de cuidados intensivos para estabiliza&#xE7;&#xE3;o hemodin&#xE2;mica e hidroeletrol&#xED;tica. Ap&#xF3;s alta da unidade de terapia intensiva, o tratamento foi substituido pelo antif&#xFA;ngico posaconazol via oral, com deteriora&#xE7;&#xE3;o do quadro cl&#xED;nico.</p>
        <p>O paciente retornou para o HIAE em agosto de 2010, e um novo exame de resson&#xE2;ncia magn&#xE9;tica de cr&#xE2;nio evidenciou progress&#xE3;o da les&#xE3;o infiltrativa (<xref ref-type="fig" rid="f09">Figura 4</xref>), acometendo hemiface esquerda, &#xF3;rbitas e maior extens&#xE3;o dos seios etmoidal e esfenoidal, al&#xE9;m de acometimento paquimen&#xED;ngeo. A piora cl&#xED;nica, com a presen&#xE7;a de febre persistente e de complica&#xE7;&#xF5;es inerentes &#xE0; interna&#xE7;&#xE3;o hospilar, levaram ao esquema terap&#xEA;utico com anfotericina B, caspofungina, terbinafina, itraconazol, corticoide, aciclovir, eritropoetina, ceftriaxone, cefepime e ciprofloxacina em tempos diferentes, al&#xE9;m de oxigenoterapia hiperb&#xE1;rica. Quinze dias ap&#xF3;s a &#xFA;ltima se&#xE7;&#xE3;o da c&#xE2;mera hiperb&#xE1;rica, a resson&#xE2;ncia magn&#xE9;tica j&#xE1; mostrava les&#xE3;o localizada sem sinais de invas&#xE3;o de tecidos s&#xE3;os (<xref ref-type="fig" rid="f10">Figura 5</xref>). Ap&#xF3;s aproximadamente 2 meses, submeteu-se &#xE0; nova limpeza cir&#xFA;rgica, dessa vez com melhora da sintomatologia obstrutiva e praticamente cura da doen&#xE7;a.</p>
        <p>
<fig id="f09" orientation="portrait" position="float"><label>Figura 4</label><caption><title>Espessamento e realce envolvendo bulbo e nervos olfat&#xF3;rios e soalho da fossa craniana anterior. H&#xE1; deslocamento da base do lobo frontal esquerdo, e les&#xE3;o sugestiva de inflama&#xE7;&#xE3;o e/ou edema nos giros retos e frontais orbit&#xE1;rios deste lado</title></caption><graphic xlink:href="1679-4508-eins-12-3-0347-gf04-pt"/></fig>
</p>
        <p>
<fig id="f10" orientation="portrait" position="float"><label>Figura 5</label><caption><title>Diminui&#xE7;&#xE3;o da les&#xE3;o infiltrativa que acomete o tecido subcut&#xE2;neo, principalmente periorbit&#xE1;rio esquerdo, e redu&#xE7;&#xE3;o da proptose do mesmo lado. Redu&#xE7;&#xE3;o da les&#xE3;o na rinofaringe, hipofaringe e seios da face, em compara&#xE7;&#xE3;o com os anteriores</title></caption><graphic xlink:href="1679-4508-eins-12-3-0347-gf05-pt"/></fig>
</p>
      </sec>
      <sec>
        <title>DISCUSS&#xC3;O</title>
        <p>
<italic>Conidiobollus sp</italic> &#xE9; um sapr&#xF3;fita do solo e seus prop&#xE1;gulos est&#xE3;o presentes na vegeta&#xE7;&#xE3;o em geral. Pode parasitar artr&#xF3;podes, sendo a infec&#xE7;&#xE3;o humana acidental.<sup>(<xref rid="B10" ref-type="bibr">10</xref>)</sup> A contamina&#xE7;&#xE3;o com o fungo se d&#xE1; por via inalat&#xF3;ria ou inocula&#xE7;&#xE3;o direta, como no caso do paciente descrito.<sup>(<xref rid="B8" ref-type="bibr">8</xref>)</sup>
</p>
        <p>O quadro cl&#xED;nico inicial, com les&#xE3;o nasal de crescimento r&#xE1;pido provocando sinais obstrutivos que, em poucas semanas, difunde-se para a regi&#xE3;o periorbit&#xE1;ria, causando edema, ptose e proptose, &#xE9; a apresenta&#xE7;&#xE3;o mais comum da doen&#xE7;a.<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup>
</p>
        <p>A demora de cerca de 3 meses at&#xE9; o diagn&#xF3;stico definitivo justifica a alta morbidade da doen&#xE7;a e pode ser explicada pelo grande leque de diagn&#xF3;sticos diferenciais para os sintomas iniciais.<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup> A les&#xE3;o de pele foi inicialmente tratada como impetigo e os sintomas obstrutivos foram tratados como sinusite. A aus&#xEA;ncia de resposta terap&#xEA;utica resultou na limpeza cir&#xFA;rgica e na bi&#xF3;psia.<sup>(<xref rid="B3" ref-type="bibr">3</xref>)</sup>
</p>
        <p>&#xC9; importante considerar que a anfotericina B por via intravenosa tem sido apontada como tratamento de escolha.<sup>(<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>)</sup> No paciente em quest&#xE3;o, esse fato ficou bem documentado, uma vez que, nos per&#xED;odos nos quais ele recebeu essa droga pela via adequada, a resposta foi mais satisfat&#xF3;ria. No entanto, para que o tratamento possa ser feito de modo completo, s&#xE3;o indispens&#xE1;veis os cuidados com a administra&#xE7;&#xE3;o do medicamento, a fim de evitar os efeitos adversos tamb&#xE9;m observados nesta crian&#xE7;a.</p>
        <p>A oxigenoterapia hiperb&#xE1;rica pode ter contribuido para a melhora, embora n&#xE3;o existam evid&#xEA;ncias consistentes sobre seu emprego nessa indica&#xE7;&#xE3;o.<sup>(<xref rid="B10" ref-type="bibr">10</xref>)</sup> Finalmente, a limpeza cir&#xFA;rgica &#xE9; parte essencial da estrat&#xE9;gia terap&#xEA;utica, j&#xE1; que retira o m&#xE1;ximo de material infectado poss&#xED;vel e permite viabilizar a drenagem sinusal, como observado no caso, devendo seu emprego ser enfatizado.<sup>(<xref rid="B7" ref-type="bibr">7</xref>)</sup>
</p>
      </sec>
      <sec>
        <title>CONSIDERA&#xC7;&#xD5;ES FINAIS</title>
        <p>A zigomicose &#xE9; uma doen&#xE7;a f&#xFA;ngica grave, que pode acometer tanto pessoas imunocompetentes como aqueles com a imunidade comprometida.</p>
        <p>A literatura mostra que a rapidez no diagn&#xF3;stico e o in&#xED;cio precoce do tratamento adequado s&#xE3;o fundamentais para o progn&#xF3;stico da doen&#xE7;a. Por&#xE9;m, o paciente descrito no caso, embora tenha tido um atraso no diagn&#xF3;stico, evoluiu de forma favor&#xE1;vel, devido &#xE0;s m&#xE1;ximas terap&#xEA;uticas empregadas.</p>
      </sec>
    </body>
  </sub-article>
</article>
</pmc-articleset>
